1. 594 BT-001, an oncolytic vaccinia virus armed with a Treg-depleting human recombinant anti-CTLA4 antibody and GM-CSF to target the tumor microenvironment. (9th November 2020) Authors: Semmrich, Monika; Marchand, Jean-Baptiste; Fend, Laetitia; Rehn, Matilda; Silvestre, Nathalie; Mårtensson, Linda; Foloppe, Johann; Teige, Ingrid; Quéméneur, Eric; Frendeus, Björn Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A356 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 594 BT-001, an oncolytic vaccinia virus armed with a Treg-depleting human recombinant anti-CTLA4 antibody and GM-CSF to target the tumor microenvironment. (9th November 2020) Authors: Semmrich, Monika; Marchand, Jean-Baptiste; Fend, Laetitia; Rehn, Matilda; Silvestre, Nathalie; Mårtensson, Linda; Foloppe, Johann; Teige, Ingrid; Quéméneur, Eric; Frendeus, Björn Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A629 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 725 Pre-clinical development of TNFR2 ligand-blocking BI-1808 for cancer immunotherapy. (9th November 2020) Authors: Mårtensson, Linda; Kovacek, Mathilda; Holmkvist, Petra; Semmrich, Monika; Svensson, Carolin; Blidberg, Therese; Roos, Carl; McAllister, Andres; Demiri, Mimoza; Borggren, Marie; Karlsson, Ingrid; Frendeus, Björn; Teige, Ingrid Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A434 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 725 Pre-clinical development of TNFR2 ligand-blocking BI-1808 for cancer immunotherapy. (9th November 2020) Authors: Mårtensson, Linda; Kovacek, Mathilda; Holmkvist, Petra; Semmrich, Monika; Svensson, Carolin; Blidberg, Therese; Roos, Carl; McAllister, Andres; Demiri, Mimoza; Borggren, Marie; Karlsson, Ingrid; Frendeus, Björn; Teige, Ingrid Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A768 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Domain binding and isotype dictate the activity of anti-human OX40 antibodies. Issue 2 (21st December 2020) Authors: Griffiths, Jordana; Hussain, Khiyam; Smith, Hannah L; Sanders, Theodore; Cox, Kerry L; Semmrich, Monika; Mårtensson, Linda; Kim, Jinny; Inzhelevskaya, Tatyana; Penfold, Chris A; Tutt, Alison L; Mockridge, C Ian; Chan, HT Claude; English, Vikki; French, Ruth F; Teige, Ingrid; Al-Shamkhani, Aymen; ... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Domain binding and isotype dictate the activity of anti-human OX40 antibodies. Issue 2 (21st December 2020) Authors: Griffiths, Jordana; Hussain, Khiyam; Smith, Hannah L; Sanders, Theodore; Cox, Kerry L; Semmrich, Monika; Mårtensson, Linda; Kim, Jinny; Inzhelevskaya, Tatyana; Penfold, Chris A; Tutt, Alison L; Mockridge, C Ian; Chan, HT Claude; English, Vikki; French, Ruth F; Teige, Ingrid; Al-Shamkhani, Aymen; ... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8+ T cell immunity to reject 'cold' tumors. Issue 1 (19th January 2022) Authors: Semmrich, Monika; Marchand, Jean-Baptiste; Fend, Laetitia; Rehn, Matilda; Remy, Christelle; Holmkvist, Petra; Silvestre, Nathalie; Svensson, Carolin; Kleinpeter, Patricia; Deforges, Jules; Junghus, Fred; Cleary, Kirstie L; Bodén, Mimoza; Mårtensson, Linda; Foloppe, Johann; Teige, Ingrid; Quéméneu... Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗